Xilio Therapeutics, Inc.XLONASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank40
Studio
Year-over-Year Change

Return on invested capital

Latest
-134.62%
Near historical average
Percentile
P40
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-126.11%
Historical baseline
PeriodValueYoY Change
2024-134.62%+17.9%
2023-163.89%-131.0%
2022-70.96%-98.3%
2021-35.79%+88.8%
2020-318.32%-862.2%
2019-33.08%-